![Darrin Beaupre](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Darrin Beaupre
Chief Tech/Sci/R&D Officer at
IDEAYA BIOSCIENCES, INC.
Net worth: - $ as of 2026-08-30
Profile
Darrin M.
Beaupre is currently Chief Medical Officer at IDEAYA Biosciences, Inc. since 2022.
Formerly, Dr. Beaupre was Chief Medical Officer at Biosplice Therapeutics, Inc. from 2020 to 2022, Head-Early Development & Immunotherapy at Pharmacyclics LLC from 2012 to 2017, Medical Director at Amgen, Inc. from 2006 to 2012, Head-Early Oncology Development at Pfizer Inc., and Assistant Professor at Moffit Cancer Center.
Education includes a doctorate from The University of Texas Medical School At Houston and undergraduate and graduate degrees from the University of Lowell.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-30 | 0 ( -.--% ) | - $ | 2026-08-30 |
Darrin Beaupre active positions
| Companies | Position | Start |
|---|---|---|
| IDEAYA BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 2022-11-20 |
Former positions of Darrin Beaupre
| Companies | Position | End |
|---|---|---|
Biosplice Therapeutics, Inc.
 Biosplice Therapeutics, Inc. BiotechnologyHealth Technology Operates as a pre-clinical research company that develops small-molecule therapeutics for osteoarthritis & cancer | Chief Tech/Sci/R&D Officer | 2022-10-31 |
| PHARMACYCLICS, INC. | Corporate Officer/Principal | 2017-01-31 |
| AMGEN INC. | Chief Tech/Sci/R&D Officer | 2012-09-30 |
Moffit Cancer Center | Corporate Officer/Principal | - |
| PFIZER INC. | Chief Tech/Sci/R&D Officer | - |
Training of Darrin Beaupre
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
62
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs intended to treat cancer and atherosclerosis | Health Technology |
University of Lowell
 University of Lowell Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Texas Medical School At Houston
 The University of Texas Medical School At Houston Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biosplice Therapeutics, Inc.
Biosplice Therapeutics, Inc. BiotechnologyHealth Technology Operates as a pre-clinical research company that develops small-molecule therapeutics for osteoarthritis & cancer | Health Technology |
IDEAYA Biosciences, Inc.
 IDEAYA Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as oncology-focused precision medicine company which develops and sells cancer therapeutics | Health Technology |
Moffit Cancer Center |
- Stock Market
- Insiders
- Darrin Beaupre
